Table 1 Characteristics of Cohort studies
Study ID | Population | Place/Source | Age(years) | Sample Size/Follow-up | OR/HR/RR (CI95%) | Results | NOS |
|---|---|---|---|---|---|---|---|
[3] | cardiovascular risk factors or atypical chest pain | South Korea | 56.4 ± 7.2 | 1015 / 39 month | aHR:1.28 (1.04, 1.67) | Association in Univariate Analysis | Good |
[26] | free of clinical cardiovascular disease | USA/MESA | 61.8 | 6067/ 6.5 ± 3.5 years | RR: 0.97 (0.92, 1.02) | No association | Good |
[40] | baseline zero CAC score | Taiwan | 51.17 ± 8.24 | 830/4.55 ± 2.42 years | OR: 1.399 (0.923, 2.123) | No association | Good |
[34] | Asymptomatic intermediate ASCVD risk factors | USA/EISNER | 62.5 ± 8.3 | 1207/4 years | OR: 0.95 | No association | Good |
[35] | random sample from the general population | Denmark | 55.39 ± 5.01 | 1006/ 5 years | IRR: 1.01 (0.96, 1.06) | No association | Good |
[36] | with an enhanced risk for CAD | Germany | 58.8 ± 10.0 | 94/1.9 ± 0.5 years | N/A | No association | Good |
[37] | classified as low risk for CHD events | USA/MESA | 60.4 ± 9.2 | 2620/2.5 years | OR: 1.07 (0.97, 1.18) | No association | Good |
[38] | no history of signs of CHD, hypertension, inflammatory diseases, or allergies | United Kingdom | 63.36 ± 5.9 | 466/ 3 years | OR: 0.99 (0.89, 1.10) | No association | Good |
[39] | healthy asymptomatic | USA/PACC | 47.9 ± 2.8 | 180/ 2 years | OR: 1.23 (0.73, 2.08) | No association | Good |